Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 1, 2010
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sciclone Pharmaceuticals Inc
| -1.29M |
—
|
—
| -100.00% |
0
|
Jun 29
| |||||||
Sciclone Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Regenerx Biopharmaceuticals Inc
| 1.22M |
$0.82 | $999,999.84 | +17.53% | 8.18M |
Oct 8
| |||||||
Regenerx Biopharmaceuticals Inc
| 312.5K |
$0.40 | $125,000.00 | +4.70% | 6.96M |
Jun 2
| |||||||
Regenerx Biopharmaceuticals Inc
| 1.05M |
$0.57 | $599,999.67 | +18.83% | 6.64M |
Apr 13
| |||||||
Regenerx Biopharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Regenerx Biopharmaceuticals Inc
| 1.03M |
$1.45 | $1,499,998.90 | +22.71% | 5.59M |
Dec 10
| |||||||
Regenerx Biopharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Questcor Pharmaceuticals Inc
| -2.20M |
$4.95 | -$10,890,000.00 | -30.95% | 4.91M |
Aug 13
| |||||||
Questcor Pharmaceuticals Inc
| -100.00K |
$4.91 | -$491,470.00 | -1.39% | 7.11M |
Jul 16
| |||||||
Questcor Pharmaceuticals Inc
| -31.34K |
$5.20 | -$162,957.60 | -0.43% | 7.21M |
Jul 2
| |||||||
Questcor Pharmaceuticals Inc
| -8.00K |
$5.20 | -$41,600.00 | -0.11% | 7.24M |
Jun 5 - Jun 6
| |||||||
Questcor Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Questcor Pharmaceuticals Inc
|
0
|
$4.68 |
—
|
—
| 7.25M |
Nov 20
| |||||||
Questcor Pharmaceuticals Inc
|
0
|
$1.50 |
—
|
—
| 9.5M |
Dec 20
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||